The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Samsung C&T Corp
KRX:02826K
|
KR |
|
TUI AG
OTC:TUIFF
|
DE |
|
Hermes International SCA
OTC:HESAY
|
FR |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
US |
|
Aviva PLC
LSE:AV
|
UK |
|
P
|
Phillips 66
SWB:R66
|
US |
|
S
|
Sanofi SA
XHAM:SNW
|
FR |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
CL |
|
C
|
CF Industries Holdings Inc
DUS:C4F
|
US |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
K
|
Kuehne + Nagel International AG
XMUN:KNIA
|
CH |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
E
|
Entergy Corp
SWB:ETY
|
US |
|
S
|
Sherwin-Williams Co
F:SJ3
|
US |
|
Site Centers Corp
F:DDR
|
US |
|
C
|
CenterPoint Energy Inc
XMUN:HOU
|
US |
|
TTM Technologies Inc
F:TT1
|
US |
|
T
|
TUI AG
SWB:TUI1
|
DE |
|
C
|
Cemex SAB de CV
SWB:CEXA
|
MX |
|
Aena SME SA
OTC:ANNSF
|
ES |
|
E
|
EQT Corp
DUS:EQ6
|
US |
|
B
|
Bridgestone Corp
XMUN:BGT
|
JP |
|
Swiss Prime Site AG
F:SU1N
|
CH |
|
A
|
Altria Group Inc
F:PHM7
|
US |
Samsung C&T Corp (02826K)’s 12-month stock price forecast through September 2027 has a consensus target of ₩328 425.53, implying 40% upside. The forecast is based on price targets from 20 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
02826K is 328 425.53 KRW with a low forecast of 234 148.09 KRW and a high forecast of 449 653.19 KRW.
Over the last 12 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 3 years is 8%.
Over the last 12 years, the compound annual growth rate for Gross Profit has been 24%. The projected CAGR for the next 3 years is 9%.
Over the last 12 years, the compound annual growth rate for Operating Income has been 33%. The projected CAGR for the next 3 years is 15%.
Over the last 12 years, the compound annual growth rate for Pre-Tax Income has been 77%. The projected CAGR for the next 3 years is 21%.
Over the last 12 years, the compound annual growth rate for Net Income has been 39%. The projected CAGR for the next 3 years is 20%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more